ClinicalTrials.gov
ClinicalTrials.gov Menu

Counseling During Pulmonary Rehabilitation

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02455206
Recruitment Status : Recruiting
First Posted : May 27, 2015
Last Update Posted : July 17, 2018
Sponsor:
Collaborators:
Kantonsspital Winterthur KSW
Schweizer Lungenliga
Information provided by (Responsible Party):
Anne-Kathrin Rausch, Zurich University of Applied Sciences

Brief Summary:
The purpose of this study is to investigate if a physical activity counseling program during pulmonary rehabilitation increases the physical activity level in daily life in patients with Chronic Obstructive Pulmonary Disease.

Condition or disease Intervention/treatment Phase
COPD Behavioral: physical activity counseling Behavioral: Usual care Not Applicable

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 62 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Effect of Counseling During Pulmonary Rehabilitation on Self-determined Motivation Towards Physical Activity in Patients With Chronic Obstructive Pulmonary Disease
Study Start Date : October 2015
Estimated Primary Completion Date : January 2020
Estimated Study Completion Date : January 2020

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Rehabilitation

Arm Intervention/treatment
Active Comparator: Usual Care
outpatient pulmonary Rehabilitation program
Behavioral: Usual care
Experimental: Counseling
outpatient pulmonary Rehabilitation program plus physical activity counseling
Behavioral: physical activity counseling
5 face-to-face sessions a 30 minutes during 12 weeks pulmonary rehabilitation program.




Primary Outcome Measures :
  1. number of steps per day [ Time Frame: 6 months ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   40 Years to 90 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • confirmed COPD (GOLD stages B-D) according to GOLD-guidelines

Exclusion Criteria:

  • Mental or physical disability (mini-mental score <20) precluding informed consent or compliance with the protocol
  • morphine medication
  • Primary diagnosis of heart failure
  • Uncontrolled arrhythmias causing symptoms or hemodynamic compromise
  • Severe co-morbidity (acute coronary syndrome, unstable angina terminal renal failure, concomitant pulmonary embolism, very severe pneumonia: CURB65>3)
  • Severe untreated arterial hypertension at rest (> 200 mm Hg systolic, > 120 mm Hg diastolic)

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02455206


Contacts
Contact: Anne-Kathrin Rausch, MSc 0041 58 934 69 65 rauh@zhaw.ch

Locations
Switzerland
Kantonsspital Recruiting
Winterthur, Switzerland
Contact: Hess Thomas    0522662332      
Contact: Beyer Swantje    0522662333      
Sponsors and Collaborators
Zurich University of Applied Sciences
Kantonsspital Winterthur KSW
Schweizer Lungenliga
Investigators
Principal Investigator: Thomas Hess, Dr med Kantonsspital Winterthur KSW

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Anne-Kathrin Rausch, MSc, Zurich University of Applied Sciences
ClinicalTrials.gov Identifier: NCT02455206     History of Changes
Other Study ID Numbers: KEK-ZH-Nr. 2015-0179
First Posted: May 27, 2015    Key Record Dates
Last Update Posted: July 17, 2018
Last Verified: July 2018